News of the WeekInfectious Diseases

Australia to Test 'Mosquito Vaccine' Against Human Disease

Science  10 Dec 2010:
Vol. 330, Issue 6010, pp. 1460-1461
DOI: 10.1126/science.330.6010.1460

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

In January, entomologists will start deploying a strange bacterium called Wolbachia pipientis in an attempt to halt disease transmission by mosquitoes. Their target is Aedes aegypti, the mosquito that transmits dengue, a human viral disease that causes crippling joint and muscle pains. Recent studies have shown that infection with Wolbachia makes mosquitoes resistant to the dengue virus. Now, a team at the University of Queensland in Brisbane, Australia, wants to test whether they can spread Wolbachia in the wild by setting free small numbers of mosquitoes infected with the microbe. It should work, they say—and it did in cage trials—because Wolbachia plays weird tricks on insects' sex lives, helping it spread like wildfire.

Related Content